ArticleInvestigational new drugs2015

An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.

Robert M Jotte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.